BBIO vs MSFT: Which Stock is Better?
Side-by-side comparison of BridgeBio Pharma Inc and Microsoft Corporation in 2026
BBIO
BridgeBio Pharma Inc
$76.65
MSFT
Microsoft Corporation
$499.32
Key Metrics Comparison
| Metric | BBIO | MSFT | Winner |
|---|---|---|---|
| Market Cap | $13.24B | $3.71T | MSFT |
| P/E Ratio | N/A | 33.89 | BBIO |
| EPS (TTM) | $N/A | $14.08 | MSFT |
| Revenue Growth | 2285.3% | 18.4% | BBIO |
| Gross Margin | 0.0% | 67.9% | MSFT |
Analyze BBIO
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is BBIO or MSFT a better investment?
Comparing BBIO and MSFT: BridgeBio Pharma Inc has a market cap of $13.24B while Microsoft Corporation has $3.71T. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between BBIO and MSFT?
BBIO (BridgeBio Pharma Inc) and MSFT (Microsoft Corporation) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: BBIO or MSFT?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: BBIO or MSFT?
BBIO has higher revenue growth at 2285.3% vs 18.4% for MSFT.
Which company is more profitable: BBIO or MSFT?
Microsoft Corporation (MSFT) has higher gross margins at 67.9% compared to 0.0% for BBIO.
Which is the larger company: BBIO or MSFT?
Microsoft Corporation (MSFT) is larger with a market cap of $3.71T compared to $13.24B for BBIO.
Should I buy BBIO or MSFT in 2026?
Both BBIO and MSFT have investment merit. BBIO trades at $76.65 while MSFT trades at $499.32. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between BBIO and MSFT stock?
Key differences: Market Cap ($13.24B vs $3.71T), P/E Ratio (N/A vs 33.9x), Revenue Growth (2285.3% vs 18.4%), Gross Margin (0.0% vs 67.9%).
Should I buy BBIO or MSFT in 2026?
The choice between BBIO and MSFT depends on your investment goals. BBIO shows higher revenue growth (2285.3%). MSFT has better margins (67.9%). Consider your risk tolerance and time horizon.
What is the market cap comparison between BBIO and MSFT?
BBIO (BridgeBio Pharma Inc) has a market cap of $13.24B, while MSFT (Microsoft Corporation) has a market cap of $3.71T. MSFT is the larger company by market value.